United Therapeutics Corporation (UTHR)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

United Therapeutics Corporation (UTHR) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $21.34B, a trailing price-to-earnings ratio of 17.8 and a free-cash-flow yield of 4.3%. Over the most recent reported fiscal year, revenue grew 10.6% and free cash flow per share fell 3.0%.

Market cap	$21.34B
Trailing P/E	17.8
FCF yield	4.3%
Revenue growth (YoY)	+10.6%
EPS growth (YoY)	+10.4%
FCF/share growth (YoY)	-3.0%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live UTHR data on Nama Insights →

Recent Congressional trades

United Therapeutics Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 21, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Nov 21, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025